Literature DB >> 26809341

Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Saleh Al-Quraishy1, Mohamed A Dkhil2,3, Suliman Alomar2, Abdel Azeem S Abdel-Baki2,4, Denis Delic5, Frank Wunderlich6, Marcos J Araúzo-Bravo7,8.   

Abstract

Protective vaccination induces self-healing of otherwise lethal blood-stage infections of Plasmodium chabaudi malaria. Here, we investigate mRNA expression patterns of all 12 members of the Toll-like receptor (Tlr) gene family in the liver, a major effector organ against blood-stage malaria, during lethal and vaccination-induced self-healing infections of P. chabaudi in female Balb/c mice. Gene expression microarrays reveal that all 12 Tlr genes are constitutively expressed, though at varying levels, and specifically respond to infection. Protective vaccination does not affect constitutive expression of any of the 12 Tlr genes but leads to differential expression (p < 0.05) of seven Tlrs (1, 2, 4, 7, 8, 12, and 13) in response to malaria. Quantitative PCR substantiates differential expression at p < 0.01. There is an increased expression of Tlr2 by approximately five-fold on day 1 post-infection (p.i.) and Tlr1 by approximately threefold on day 4 p.i.. At peak parasitemia on day 8 p.i., none of the 12 Tlrs display any differential expression. After peak parasitemia, towards the end of the crisis phase on day 11 p.i., expression of Tlrs 1, 4, and 12 is increased by approximately four-, two-, and three-fold, respectively, and that of Tlr7 is decreased by approximately two-fold. Collectively, our data suggest that though all 12 members of the Tlr gene family are specifically responsive to malaria in the liver, not only Tlr2 at the early stage of infection but also the Tlrs 1, 4, 7, and 12 towards the end of crisis phase are critical for vaccination-induced resolution and survival of otherwise lethal blood-stage malaria.

Entities:  

Keywords:  Blood-stage malaria; Liver; Plasmodium chabaudi; Protective vaccination; Toll-like receptors; mRNA expression

Mesh:

Substances:

Year:  2016        PMID: 26809341     DOI: 10.1007/s00436-016-4923-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  64 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation.

Authors:  Olivia Simone; Maria Teresa Bejarano; Susan K Pierce; Salvatore Antonaci; Mats Wahlgren; Marita Troye-Blomberg; Daria Donati
Journal:  Acta Trop       Date:  2011-05-19       Impact factor: 3.112

Review 3.  Autoimmune hepatitis--Update 2015.

Authors:  Michael P Manns; Ansgar W Lohse; Diego Vergani
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 4.  The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.

Authors:  John P Vasilakos; Mark A Tomai
Journal:  Expert Rev Vaccines       Date:  2013-07       Impact factor: 5.217

5.  Cryptic disposition of antigenic parasite proteins in plasma membranes of erythrocytes infected with Plasmodium chabaudi.

Authors:  F Wunderlich; M Helwig; G Schillinger; V Speth
Journal:  Mol Biochem Parasitol       Date:  1988-07       Impact factor: 1.759

6.  Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Authors:  Daniel Carapau; Robert Mitchell; Adéla Nacer; Alan Shaw; Caroline Othoro; Ute Frevert; Elizabeth Nardin
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 7.  TLR-mediated cell signaling by malaria GPIs.

Authors:  D Channe Gowda
Journal:  Trends Parasitol       Date:  2007-11-05

8.  Malaria modifies neonatal and early-life toll-like receptor cytokine responses.

Authors:  Komi Gbédandé; Stefania Varani; Samad Ibitokou; Parfait Houngbegnon; Sophie Borgella; Odilon Nouatin; Sem Ezinmegnon; Adicatou-Laï Adeothy; Gilles Cottrell; Achille Massougbodji; Kabirou Moutairou; Marita Troye-Blomberg; Philippe Deloron; Nadine Fievet; Adrian J F Luty
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 9.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

Review 10.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

View more
  1 in total

1.  Protective Vaccination Reshapes Hepatic Response to Blood-Stage Malaria of Genes Preferentially Expressed by NK Cells.

Authors:  Marcos J Araúzo-Bravo; Denis Delic; Daniela Gerovska; Frank Wunderlich
Journal:  Vaccines (Basel)       Date:  2020-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.